2015 Archived Content


Stories and Videos from Next Generation Dx Summit 2015 


Cross-Industry Diagnostic Experts Discuss Balancing Innovation & Regulation

2015 PAMA Update: Impact on Molecular Tests

Next Generation Dx Summit 2015 Exhibitor Testimonials

2015 Plenary Session

In the Best Interest of the Patient: Balancing Innovation and Regulation

Co-Organized withAMP

Elaine LyonModerator: Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP (AMP 2014 President and Member, AMP Professional Relations Committee)


Jordan S. LaserJordan S. Laser, M.D., Medical Director, Pathology and Laboratory Medicine, North Shore Long Island Jewish Health System (Member, AMP Professional Relations Committee)

Jamie McDonaldJamie McDonald, MS, Licensed Genetic Counselor, Co-Director, HHT Center of Excellence; Assistant Professor, Department of Pathology, University of Utah

Stephen DayStephen P. Day, Ph.D., IVD Consultant (Member, AMP Professional Relations Committee)


Bruce QuinnModerator: Bruce Quinn, M.D., Ph.D., Senior Director, FaegreBD Consulting

The Impact of PAMA on Molecular Tests

Julie KhaniJulie Khani, Senior Vice President, American Clinical Laboratory Association


John F. WarrenJohn F. Warren, Senior Director, McDermott+Consulting LLC

Donna PolizioDonna Polizio, Senior Director, Managed Care & Reimbursement, Genomic Health

Paul W. RadenskyPaul W. Radensky, M.D., Partner, Health Products Regulation Group, McDermott Will & Emery LLP

Event Features

  • Form partnerships with major players in the evolving areas of diagnostics
  • Gain a comprehensive up-to-date view of diagnostics
  • Gather important industry announcements 
  • Network with 950+ attendees
    from around the world
  • Hear late-breaking news on LDTs and PAMA in the Plenary session
  • Connect with attendees using CHI’s Intro-Net
  • Review latest technologies in the poster competition
  • Choose from a range of in-depth short courses with topic experts
  • View innovative products and novel platforms in the exhibit hall


The 2015 Next Generation Dx Summit Highlighted the Immense Opportunity and Exciting Changes Happening in the Diagnostics Industry

On August 18-20, Next Generation Dx Summit once again brought together all the major players in the diagnostics community to navigate the research advancements and technologies responsible for creating immense opportunity in the industry. Through more than 130 scientific presentations, cross-industry regulatory and reimbursement updates, and collaborative discussions throughout the active exhibit hall, attendees left with the insight needed to continue maximizing the impact the field has on precision medicine and health outcomes. A record-breaking 950+ attendees from 29 countries participated.

A special thank you to the speaking faculty, attendees, sponsors, exhibitors and media who make this event such a success each year!

Join the Community at Next Generation Dx Summit 2016

August 23-25, 2016 at the Grand Hyatt Washington, Washington, DC

Send topic suggestions and speaker referrals to:
Christina Lingham, Executive Director, Conferences
+1 781-972-5464 |  clingham@healthtech.com

Contact us to learn more about exhibit and sponsorship:
Joseph Vacca, Associate Director, Business Development
+1 781-972-5431 | jvacca@healthtech.com

2015 Conference Programs

2015 Short Courses - View Details

  • Use of FFPE/Fixed Tissues for Clinical Research
  • Method Validation According to CLSI Guidelines
  • Practical Considerations for NGS Data Analysis and Interpretation
  • Microfluidics for Point-of-Care
  • Establishing the Value of Diagnostic Tests
  • NGS as a Diagnostics Platform
  • Detection and Characterization of Circulating Biomarkers
  • Regulatory Compliance in Molecular Diagnostics
  • Use of CLIA-Waived POC and Rapid Diagnostic Tests in Community Pharmacies
  • NGS for Infectious Disease Diagnostics
  • Regulatory and Reimbursement Considerations with NGS and Other Multiplex Assays

Attendee Testimonials

"The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and learning from the leaders in the field. This is a great meeting for anyone who is serious about pursuing diagnostic technologies anywhere from research to commercialization."
Program Director, Fluxion Biosciences

"The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board."
Vice President, Diagnostics, GlaxoSmithKline

 "As we begin to move from a centralized lab to a point-of-care setting we have faced many challenges. It has been a very rewarding meeting with the leaders in policy making along with the leaders in development all in the same place."
Pathology, Graves Gilbert Clinic

"Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!"
Clinical Microbiology Fellow, NIH

View More Attendee Quotes

Japan-Flag China-Simplified-Flag China-Traditional-Flag

Register by July 24 & SAVE $200!

Premier Sponsors

Corporate Sponsors

View All Sponsors